individuals, binned by -log 10 (P). The ratio of observed to expected SNPs exceeding different thresholds is shown.
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Supplementary Methods
QT measurement methods. In FHS, paper electrocardiograms recorded on Marquette machines were scanned and digital caliper measurements were made using proprietary software (eResearchTechnology, generations 1 and 2) or using Rigel 1.7.2. (AMPS, LLC, New York, NY, USA, generation 3). The QT interval was measured from the beginning of the QRS to the end of the T wave (or the nadir of the T-U when U waves were present) in two cardiac cycles from lead II, one cycle from lead V2 and one cycle from lead V5. 1 The correlation of a single cycle QT measure between two readers was 0.77 and the coefficient of variation was 2.6%, as previously published. 1 To increase precision, the average of measures from 4 cardiac cycles were used in analyses.
In the Rotterdam Study, electrocardiograms were measured on ACTA electrocardiographs (ESAOTE, Florence, Italy) and digital measurements of the QT interval were made using the Modular ECG Analysis System (MEANS). 2 The operation of the waveform recognition algorithms has been described and validated extensively. 2, 3 The MEANS program determines common QRS onset and T offset for all 12 leads together on one representative averaged beat in a 10-second recording by use of template matching techniques. A common QRS onset and T offset are determined over all 12 leads in the representative complex. The presence of U waves or low T waves in individual leads then becomes less relevant. In the Common Standards for Quantitative Electrocardiography (CSE) study, in which different ECG computer programs were compared with a group of expert cardiologists, the measurement performance of MEANS ranked among the best. 3 In the Cardiovascular Health Study, the electrocardiograms were recorded on MAC PC-DT ECG recorder (Marquette Electronics Inc, Milwaukee, WI, USA) machines and measurements of QT interval made using the Marquette 12SL algorithm, which measures the QT as a global interval measured from the median complex derived from the cardiac cycles occurring in 10 seconds. QT measures were compared to values generated using the Dalhousie Program by the EPICORE reading center, 4 which measures a global interval from a complex obtained with selective averaging of all normally conducted complexes. 12SL values with QT within 40 msec of the Dalhousie Program were accepted for use (97.4%). If the QT interval differed between the two programs by ≥40 msec (only 2.6% of ECGs), then the value closer to the median rate-corrected QT was used.
Genotyping. In FHS, genotyping was performed by Affymetrix (Santa Clara, CA, USA) using the Affymetrix 500K GeneChip array and a custom-designed gene-centric 50K MIP. Affymetrix 500K genotypes were called using the BRLMM algorithm 5 In FHS, the following exclusions were applied to exclude individuals with call rate ≤ 97%, per subject heterozygosity ± 5SD away from mean, or excess Mendelian errors resulting in 8,481 individuals with genotype regardless of phenotype and then to exclude SNPs with HWE P < 10 -6 (15,586), call rate ≤ 97% (64,511), mishap P < 10 -9 (45,361), Mendel errors >100 (4,857), minor allele frequency <0.01 (67,269), incompatible strand with HapMap genotypes (release 22, n = 2) and SNPs not present on HapMap (13,394), resulting in a set of 378,163 SNPs to be used in imputation.
In RS, genotyping was performed by the genetic laboratory of the Department of Internal Medicine, Erasmus Medical Center, Rotterdam using the Infinium II HumanHap550K Genotyping BeadChip version 3 (Illumina, San Diego, CA, USA). The Illumina 550K BeadChip array was genotyped in all participants of the original Rotterdam Study cohort with proper quality DNA samples (n = 6,449). Intensity files were analyzed using the BeadStudio Genotyping Module software v.3.1.14. A no-call threshold of 0.15 was applied to a custom-generated cluster file derived from the Illumina-provided cluster file (based on the cluster definitions applied to the HapMap CEPH cohort). In the custom-cluster file 2,308 SNPs with GenCall scores < 0.90 were visually checked by two observers and manually reclustered or zeroed accordingly. Poorly performing samples with low call rate and 10th percentile GenCall score were excluded prior to calling genotypes. Any samples with a call rate below 97.5% (n = 209), excess autosomal heterozygosity > 0.336 ~FDR < 0.1% (n = 21), mismatch between called and phenotypic sex (n = 36), or if there were outliers identified by the IBS clustering analysis clustering > 3 standard deviations away from the population mean (n = 102) or IBS probabilities > 97% (n = 129) were excluded from the analysis. In total, 5,974 genotyped samples were available after exclusions.
In CHS, genotyping was performed at the General Clinical Research Center's Phenotyping/Genotyping Laboratory at Cedars-Sinai using the Illumina 370CNV BeadChip system. Genotypes were called using the Illumina BeadStudio software as above. Samples were excluded from analysis for sex mismatch, discordance with prior genotyping, or call rate < 95%. SNPs were excluded from analysis for HWE p < 10 -5 ; SNPs with call rates < 95% were manually reclustered using the Illumina software. All three studies make use of genotypes that were not specifically generated to examine the genetic basis of QT interval duration. Associations of poorly imputed SNPs were validated by re-genotyping FHS samples at the Broad Institute using the Sequenom platform (San Diego, CA, USA) and RS samples at the Erasmus Medical Center using Taqman MGB platform using Assays-by-Design (Applied Biosystems, Foster City, CA, USA). In RS, the following exclusions were applied to identify 512,349 SNPs to be used for imputation: HWE P < 10 -6 , call rate ≤ 98% and minor allele frequency < 0.01. In total 49,117 SNPs were excluded. For setting model parameters 200 random subjects were selected and used for every chromosome to estimate error and recombination rate (with flags --greedy, --rounds 100). Imputation was then performed to impute genotypes oriented to the positive strand of the human genome reference sequence for all autosomal SNPs in HapMap CEU using release 22, build 36. For each SNP in each individual, imputation results are reported as an allele dosage. In CHS, the following exclusions were applied to identify a final set of 332,946 SNPs: call rate >95%, HWE P > 10 -5 , 2 duplicate errors or Mendelian inconsistencies (for reference CEPH trios). Imputation was performed using BIMBAM 8 v0.95 with reference to HapMap CEU using release 21a, build 35 using one round of imputations and the default expectation-maximization warm-ups and runs. SNPs were excluded for variance on the allele dosage ≤0.01.
Imputation

